Medical Cannabis Related News
Medicinal cannabis may play a significant role during COVID-19
Early studies indicate that medicinal cannabis may have potential in treating the symptoms of COVID-19.
COVID-19 shows no sign of slowing down just yet and...
Medical Cannabis Network Quarterly Issue 4
Welcome to the fourth edition of Medical Cannabis Network Quarterly, which examines the evolution of the cannabis industry in the face of shifting legislation,...
Medical cannabis: science and risk-based methodology
Independent consultancy NNE and venture advisory firm Volvér showcase the significance of science and risk in devising a manufacturing facility.
How can cannabis producers bring...
A resource-efficient cannabis industry starts with benchmarking
Resource Innovation Institute Executive Director Derek Smith highlights the importance of tracking resource consumption in cannabis production.
As the global COVID-19 pandemic provides a window...
LeafCann secures cannabis import licence from Australian Government
Privately-owned medicinal cannabis company LeafCann has secured a Medicinal Cannabis import licence from the Australian Government.
The licence, which will enable LeafCann to supply Australian...
People of colour must be represented across the cannabis industry
There is a renewed reckoning about the exclusion of women and people of colour from power and resources worldwide.
The cannabis industry is no exception...
Cannabis cultivation research and data
The International Cannabis Cultivation Questionnaire aims to develop a better understanding of patterns in small-scale cannabis production.
The Global Cannabis Cultivation Research Consortium (GCCRC) is...
Cloud 9 Switzerland Group: nutraceuticals and pharmaceuticals
Life sciences company Cloud 9 Switzerland prioritises patient wellbeing, product quality and innovation in clinical practice.
Cloud 9 Switzerland is a life sciences company offering...
The full spectrum politics of hemp in Ireland
Chris Allen, Executive Director of Hemp Federation Ireland, tells MCN about the Irish hemp industry.
Founded at the Humanities Institute, University College Dublin (UCD) in...
Translating medicinal cannabis regulation into a patient-centred science
The Malta Medicines Authority is steering standards of good practice into day-to-day excellence, regulating medicinal cannabis through an approach that upholds scientific quality, innovative...
The value of pre-licensing cannabis cultivation space programming
What is cultivation space planning and how can it help a production facility achieve the correct licence?
In order to understand the importance of cultivation...
The Valens Company explore the importance of edibles testing
Jeff Fallows, President of The Valens Company, explores the need for product standardisation in a uniquely challenging market.
By 2022, the global worth of the...
Cannabis regulation and policy in Australia
MCN speaks with Australia’s Therapeutic Goods Administration about medical cannabis regulation and access.
The Australian Therapeutic Goods Administration (TGA), which operates under the aegis of...
Exploring real world applications of cannabis
Dr Hance Clarke tells MCN about the Medical Cannabis Real-World Evidence clinical trial.
Dr Hance Clarke, MSc, MD, PhD, FRCPC is the Medical Director of...
Medical cannabis in Colombia: the law and the future
Medical cannabis expert Dr Sandra Carrillo details the history and future of medical cannabis in Colombia.
Dr Sandra Carrillo is a medical doctor and renowned...
Shaping future cannabis strategy at the GCI Europe Summit
GCI’s Cannabis Leaders’ Summit goes virtual for 2020.
The Global Cannabis Intelligence (GCI) Europe Summit will give global leaders the opportunity to network with the...
Exploring Dutch medical cannabis with Bedrocan
Ole Heil of Bedrocan, the world’s most experienced legal medical cannabis producer, tells MCN about medical cannabis in the Netherlands.
Bedrocan, the sole supplier of...
Novel Foods and the uncertain future of Europe’s hemp industry
New Frontier Data explores the potential implications of changes to the EU’s Novel Foods legislation.
In July 2020, news broke that the European Commission was...
UK regulatory landscape: import and export of medical cannabis
In this article, Eleri Williams, Associate at Hill Dickinson Life Sciences team, sets out an overview of the current legal and regulatory position on...
Top tips for safely launching your medical cannabis products in Europe
Marc Stegeman of ProPharma Group outlines the factors business owners need to consider when moving into the growing European market.
The continent of Europe consists...